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Abstract: A previously unreported chromene derivative, 1-hydroxy-12-methoxycitromycin
(1c), and four previously undescribed chromone derivatives, including pyanochromone (3b),
spirofuranochromone (4), 7-hydroxy-6-methoxy-4-oxo-3-[(1E)-3-oxobut-1-en-1-yl]-4H-chromene-5-
carboxylic acid (5), a pyranochromone dimer (6) were isolated, together with thirteen known
compounds: β-sitostenone, ergosterol 5,8-endoperoxide, citromycin (1a), 12-methoxycitromycin
(1b), myxotrichin D (1d), 12-methoxycitromycetin (1e), anhydrofulvic acid (2a), myxotrichin C (2b),
penialidin D (2c), penialidin F (3a), SPF-3059-30 (7), GKK1032B (8) and secalonic acid A (9), from
cultures of the marine sponge- associated fungus Penicillium erubescens KUFA0220. Compounds 1a–e,
2a, 3a, 4, 7–9, were tested for their antibacterial activity against Gram-positive and Gram-negative
reference and multidrug-resistant strains isolated from the environment. Only 8 exhibited an
in vitro growth inhibition of all Gram-positive bacteria whereas 9 showed growth inhibition of
methicillin-resistant Staphyllococus aureus (MRSA). None of the compounds were active against
Gram-negative bacteria tested.
Keywords: Penicillium erubescens; Aspergillaceae; marine sponge-associated fungus; Neopetrosia sp.;
chromone derivatives; GKK 1032B; pyranochromone; spirofuranochromone; antibacterial activity
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1. Introduction
The fungi of the genus Penicillium (Family Aspergillaceae) are the most common fungi occurring in
a diverse range of habitats from soil to vegetation to various food products, air, indoor environments,
and marine environments. They have a worldwide distribution and a large economic impact on
human life [1]. The marine-derived Penicillium species can be found to be associated with a variety of
marine invertebrates such as marine sponges, corals, and tunicates, as well as with fish, marine algae,
mangroves and also from the sediments; although sediments and sponges are their main sources or
hosts for producing new marine natural products. Interestingly, marine-derived Penicillium species
produce diverse structural classes of secondary metabolites such as polyketides, sterols, terpenoids,
alkaloids, among others, and more than half of these metabolites exhibited bioactivities [2].
Thus, in our ongoing search for antibiotics from marine-derived fungi from the tropical sea, we
investigated secondary metabolites from cultures of Penicillium erubescens KUFA 0220, which was
isolated from the marine sponge Neopetrosia sp., collected from the coral reef at Samaesan Island,
Chonburi province, in the Gulf of Thailand.
Chromatographic fractionation and the further purification of the crude ethyl acetate extract of
the cultures of P. erubescens KUFA 0220, furnished an unreported chromene derivative, 1-hydroxy-
12-methoxycitromycin (1c), and four previously undescribed chromone derivatives, including a
pyanochromone (3b), a spirofuranochromone (4), 7-hydroxy-6-methoxy-4-oxo-3-[(1E)-3-oxobut-1-
en-1-yl]-4H-chromene-5-carboxylic acid (5), and a pyranochromone dimer (6) (Figure 1), in addition to
thirteen known compounds: β-sitostenone [3,4], citromycin (1a) [5], 12-methoxycitromycin (1b) [5],
myxotrichin D (1d) [6], 12-methoxycitromycetin (1e) [5], anhydrofulvic acid (2a) [7,8], myxotrichin C
(2b) [6], penialidin D (2c) [9], penialidin F (3a) [9,10], SPF-3059-30 (7) [11], GKK1032B (8) [12–14] and
secalonic acid A (9) [3] (Figure 1). The structures of the previously undescribed compounds were
established based on extensive analyses of their 1D and 2D NMR as well as HRMS data while the
identity of the known compounds was elucidated by comparison of their 1H and 13C NMR data with
those reported in the literature. The absolute configuration of the stereogenic carbon of the previously
unreported 4 was established by an X-ray analysis whereas those of the previously undescribed 6 and
penialidin F (3a) were determined by comparison of their calculated and experimental ECD spectra.
Compounds 1a–e, 2a, 3a, 4, 7–9 were tested for their antibacterial activity against five
reference bacterial strains consisting of three Gram-positive (Staphylococcus aureus ATCC 29213,
Enterococcus faecium ATCC 19434 and Enterococcus faecalis ATCC 29212) and two Gram-negative bacteria
(Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853), three multidrug-resistant isolates
from the environment (MRSA S. aureus 66/1, VRE E. faecium 1/6/63 and E. faecalis B3/101) and a
clinical isolate ESBL E. coli SA/2. Some of the isolated compounds were also investigated for their
capacity to inhibit biofilm formation in the four reference strains as well as for their potential synergism
with the clinically used antibiotics against multidrug-resistant isolates from the environment.
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Figure 1. The structures of some secondary metabolites, isolated from cultures of the marine sponge-
associated fungus P. erubescens KUFA 0220. 
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1. The structures f some secondary metabolites, isolated from cultur s of th marine
sponge-associated fungus P. erubescens KUFA 0220.
. lt i i
structure of β-sitosteno e [3], ergosterol 5,8-endoper xide [4] (Figure S1), citromy in (1a) [5],
12-methoxycitromycin (1b) [5], myxotrichin D (1d) [6], 12-methoxycitro ycetin (1e) [5], anhydrofulvic
cid (2a) [7,8], myxotrichin C (2b) [6], penialidin D (2c) [9], penialidin F (3a) [9,10], SPF-3059-30
(7) [11], GKK1032B (8) [12–14], and secalonic acid A (9) [3,15] (Figure 1) were elucidat d by analysis
of their 1D and 2D NMR spectra as w ll as HRMS data, and also by comparison of their spectral
data (Figures S2–S11, S15 29, 4 50, 52 and S53) to those reported in the literature. In the case of
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GKK1032B (8), the X-ray analysis was also performed to confirm the absolute configurations of all the
stereogenic centers (Figure S51).
Compound 1c was isolated as a white solid (mp 232–233 ◦C), and its molecular formula
C14H12O6 was established based on its (+)-HRESIMS m/z 277.0715 [M + H]+, (calculated 277.0712
for C14H13O6), indicating nine degrees of unsaturation. The IR spectrum showed absorption bands
for the hydroxyl (3420 cm−1), conjugated ketone carbonyl (1662 cm−1), aromatic (1627, 1555 cm−1),
and ether (1270 cm−1) groups. The 13C NMR spectrum of 1c (Table 1, Figure S11) displayed fourteen
carbon signals which, according to DEPTs and HSQC spectra (Table 1, Figure S12), can be classified
as one conjugated ketone carbonyl (δC 174.8), seven quaternary sp2 (δC 167.3, 155.2, 152.2, 151.9,
143.6, 111.2, 105.9), three methine sp2 (δC 110.7, 106.5, 104.1), two oxymethylene sp3 (δC 62.5 and
59.5), and one methoxyl (δC 56.4) carbon. The 1H NMR spectrum (Table 1, Figure S10) showed two
aromatic singlets at δH 7.15 and 6.44, another singlet of one olefinic proton at δH 6.25, two singlets of
oxymethylene protons at δH 5.02 (2H) and 4.41 (2H), and a singlet of methoxyl protons at δH 3.80 (3H).
The general features of the 1H and 13C NMR spectra of 1c resembled those of 12-methoxycitromycin
(1b), which was previously isolated from the Australian marine-derived and terrestrial Penicillium
spp. [5], and also isolated in this work. The only difference between the two compounds is the methyl
group in 1b (δH 2.34, d, J = 0.6 Hz; δC 19.2) is replaced by a hydroxymethyl group (δH 4.41; δC 59.5)
in 1c. The position of the methoxyl group was also confirmed by the NOESY correlation from the
methoxyl protons to H-13 (δH 7.15, s) (Figure S14). Therefore, 1c is 1-hydroxy-12-methoxycitromycin.
The literature search revealed that 1c has never been previously reported.
Table 1. The 1H and 13C NMR (DMSO-d6, 500.13 and 125.4 MHz) and HMBC assignment for 1c.
Position δC, Type δH, (J in Hz) HMBC
1 59.5, CH2 4.41, brs C-2, 5
2 167.3, C - -
3 104.1, CH 6.25, s C-1, 2, 5
4 174.8, CO - -
5 111.2, C - -
6 62.6, CH2 5.02, s C-4, 5, 7, 9
7 155.2, C - -
8 105.9, C - -
9 152.2, C -
10 106.5, CH 6.44, s C-7, 8, 9, 11, 12
11 151.9, C - -
12 143.6, C - -
13 110.7, CH 7.15, s C-7, 8, 9, 11, 12
OCH3-12 56.4, CH3 3.80 C-12
The analysis of the 1H, 13C NMR (Table 2, Figures S28 and S29) and the (+)-HRESIMS spectra of
3a revealed that its planar structure was the same as that of penialidin F, previously isolated from the
culture of Penicillium janthinellum DT-F29, collected from marine sediments [9]. Curiously, even though
the authors reported the optical rotation of penialidin F as levorotatory ([α]25D −4.13, c = 1.0, MeOH),
they did not determine the absolute configuration of its stereogenic carbon (C-2). Similarly, we have
also found the optical rotation of the 3a levorotatory, ([α]25D −7.5, c = 0.04, MeOH). Since 3a was not
isolated as a suitable crystal for X-ray analysis, its calculated ECD spectrum was performed to compare
with the experimental ECD spectrum. Therefore, the conformational analysis of 3a by molecular
mechanics (MM2 and MMFF95 force fields) focused on combinations of hydroxyl 120◦ rotations and
two 3,6-dihydro-2H-pyran-2-ol ring conformations. A total of 30 conformations were energetically
minimized and ranked using a faster DFT model (smaller basis set, APFD/6-31G). The lowest three of
these, representing 99% of the model Boltzmann population, were then further energetically minimized
with a larger basis set (APFD/6-311+G(2d,p)). The most stable conformation is depicted in Figure 2
and represents 64% of the Boltzmann population while the other two amount to 25% and 11%.
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Table 2. The 1H and 13C NMR of 3a (DMSO-d6, 300.13 and 75.4 MHz) and 3b (DMSO, 500.13 and 125.4 MHz).
3a 3b
Position δC, Type δH, (J in Hz) δC, Type δH, (J in Hz)
1 28.4, CH3 1.45, s 22.4, CH3 1.44, s
2 94.2, C - 97.7, C -
3 37.5, CH2
2.55, d (17.5) 37.1, CH2
2.63, dd (17.6, 2.6)
2.87, d (17.5) 2.96, dd (17.6, 2.6)
4 158.7, C - 157.9, C -
5 113.5, C - 113.0, C -
6 56.3, CH2
4.45, s 52.7, CH2
4.22, dt (14.9, 0.9)
- 4.52, dd (14.9, 2.1)
7 173.4, CO - 173.2, CO -
8 115.4, C - 115.4, C -
9 152.1, C - 152.1, C -
10 102.7, CH 6.83, s 102.7, CH 6.83, s
11 150.8, C - 150.8, C -
12 144.3, C - 144.4, C -
13 107.4, CH 7.26, s 107.4, CH 7.26, s
OCH3 - - 48.3, CH3 3.21, s
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Figure 2. The most stable APFD/6-311+G(2d,p) conformation of 3a (C-2R). The asymmetric carbon is
presented with the hydroxyl group facing straight down.
These three models were then used to calculate the expected Boltzmann-averaged ECD spectrum
of 3a’s R enantiom r. The good fit between the calculated and experimental ECD spectra shown in
Figure 3 is enough evidence to conclude that 3 is e R enantiomer. However, the weak experimental
ECD sig al of 3a could indicate that this compound doe not xist s a pure R enantiomer but as an
enantiomeric mixture with an excess of the R enantiomer.
Compound 3b was isolated as a 1:2 mixture (estimated from the integration of the proton signals
in the 1H NMR spectrum) with myxotrichin C (2b). Based on the (+)-HRESIMS m/z 279.0878 [M + H]+,
(calculated 277.0869 for C14H15O6), the molecular formula C14H14O6 was attributed to 3b. The 1H and
13C NMR spectra of 3b (a minor compound) resembled those of penialidin F (3a) (Table 2). The 13C
NMR spectrum of 3b (Table 2, Figure S22) exhibited fourteen carbon signals which, in combination
with DEPTs and HSQC spectra (Figure S24), can be categorized as one conjugated ketone carbonyl
(δC 173.2), six quaternary sp2 (δC 157.9, 152.1, 150.8, 144.4, 115.4, 113.0), two methine sp2 (δC 107.4 and
102.7), one ketal (δC 97.7), one oxymethylene sp3 (δC 57.1), one methylene sp3 (δC 37.1), one methyl
(δC 22.4), and one methoxyl (δC 48.3) carbon. The 1H NMR spectrum (Figure S21) displayed two
aromatic singlets at δH 7.26 (H-13) and 6.83 (H-10), two pairs of geminally coupled methylene protons
at δH 4.52, dd (J = 14.9, 0.9 Hz)/4.22, dt, (J = 4.9, 2.1 Hz) and 2.63, dd (J = 17.6, 1.5 Hz)/2.96, dd (J = 1.76,
2.6 Hz), a methyl singlet at δH 1.44 and a methoxyl singlet at δH 3.21. Comparison of the 1H and
13C data of 3b with those of 3a (Table 2) led to the conclusion that 3b is a methyl ketal of 3a. This
hypothesis is confirmed not only by the molecular formula of 3b, which is 14 amu more than that of
3a, but also by the HMBC correlation (Figure S25) of the singlet of the methoxyl protons to the ketal
carbon at δC 97.7. Therefore, 3b was named penialidin G.
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The biogenesis of 2b, 3a, and 3b can be hypothesized as originated from the hexaketide
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through an intermediate (ii), in 3a (2R). Dehydration of the hemiketal in 3a furnished myxotrichin
C (2b), which underwent a nucleophilic addition of methanol (chromatographic solvent) at C-2 to
form an enantiomeric mixture of 3b. Therefore, 3b can be an artifact and not a natural product.
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Compound 4 was isolated as white crystals (mp 150–152 ◦C), and its molecular formula was
established as C13H10O6 on the basis of its (+)-HRESIMS m/z 263.0569 [M + H]+, (calculated 263.0556
for C13H11O6), indicating nine degrees of unsaturation. The IR spectrum showed absorption bands
for hydroxyl (3491, 3376 cm−1), conjugated ketone carbonyls (1679, 1661 cm−1), olefin (1648 cm−1),
aromatic (1587, 1523 cm−1), and ether (1276 cm−1) groups. The 13C NMR spectrum (Table 3, Figure S31)
displayed thirteen carbon signals which were categorized, according to the DEPTs and HSQC spectra
(Figure S33), as two conjugated ketone carbonyls (δC 198.3 and 181.6), four oxyquaternary sp2 (δC 191.4,
156.9, 155.9, 141.9), one quaternary sp2 (δC 111.1), three methine sp2 (δC 110.3, 103.8, 103.2), one
quaternary sp3 (δC 86.3), one oxymethylene sp3 (δC 69.8) and one methyl (δC 16.4) carbons. The 1H
NMR spectrum (Table 3, Figure S31) showed two aromatic singlets at δH 7.05 and 6.41, a doublet of
an olefinic proton at δH 5.68 (J = 0.6 Hz), a pair of doublets of the oxymethylene protons at δH 4.49
(J = 12.4 Hz)/4.63 (J = 12.4 Hz), and a methyl singlet at δH 2.31, in addition to a broad signal of the
hydroxyl protons at δH 10.01. The presence of the 6,7-dihydroxy-2,3-dihydro-4H-1-benzopyran-4-one
moiety was corroborated by the HMBC correlations (Table 3, Figure S34) from H-5 (δH 7.05, s) to C-4
(δC 181.6), C-6 (δC 141.9), C-7 (δC 155.9) and C-8a (δC 156.9); H-8 (δH 6.41, s) to C-4, C-4a (δC 111.1), C-6,
C-7 and C-8a, and from H2-2 (δH 4.49, d, J = 12.4 Hz/4.63, d, 12.4 Hz) to C-4 and C-8a. That another
portion of the molecule was a 5-methylfuran-3(2H)-one ring was substantiated by the COSY correlation
(Table 3, Figure S32) from the methyl singlet at δH 2.31 to H-3′ (δH 5.68, d, J = 0.6 Hz), as well as the
HMBC correlations (Table 3, Figure S34) from H-3′ to C-3 (δC 86.3), C-2′ (δC 191.4), C-4′ (δC 198.3),
and from the methyl singlet at δH 2.31 to C-2′ and C-3′ (δC 103.8). Finally, the 5-methylfuran-3(2H)-one
moiety and the 6,7-dihydroxy-2,3-dihydro-4H-1-benzopyran-4-one were connected through C-3 since
the HMBC spectrum exhibited correlations from H-2 (δH 4.49, d, J = 12.4 Hz) to C-3 and C-4′,
and from H-3′ to C-3. Therefore, the planar structure of 4 corresponds to 5′-methyl-2H,3′H,4H-spiro
[1-benzopyran-3,2′-furan]-3′,4-dione. Since 4 was obtained as a suitable crystal, an X-ray analysis was
carried out to determine the absolute configuration of the stereogenic carbon (C-3).
Table 3. The 1H and 13C NMR (DMSO-d6, 300.13 and 75.4 MHz) and HMBC assignment for 4.
Position ∆c, Type δH, (J in Hz) COSY HMBC
2a 69.8, CH2
4.49, d (12.4) 2b C-4, 4′, 8a
2b 4.63, d (12.4) 2a C-3, 4, 4′, 8a-
3 86.3, C - - -
4 181.6, CO - - -
4a 111.1, C - - -
5 110.3, CH 7.05, s - C-4, 6, 7, 8a
6 141.9, C - - -
7 155.9, C - - -
8 103.2, CH 6.41, s - C-4, 4a, 6, 7, 8a
8a 156.9, C - - -
2′ 191.4, C - - -
3′ 103.8, CH 5.68, d (0.8) 5′ C-2′, 3, 4′
4′ 198.3, CO - - -
5′ 16.4, CH3 2.31, s 3′ C-2′, 3′
OH - 10.01, brs - -
The ORTEP view, shown in Figure 5, not only confirmed the proposed structure for 4 but also
determined unequivocally the absolute configuration of C-3 as 3S. Therefore, the absolute structure of
4 is (3S)-6,7-dihydroxy-5′-methyl-3′H,4H-spiro[chromene-3,2′-furan]-3′,4-dione, which was named
erubescenschromone A.
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Compound 5 was isolated as a white solid (mp 276–277 ◦C), and displayed its (+)-HRESIMS
m/z at 305.0667 [M + H]+, (calculated 305.0661 for C15H13O7). Therefore, its molecular formula
was established as C15H12O7, indicating ten degrees of unsaturation. The IR spectrum exhibited
absorption bands for hydroxyl (3446 cm−1), conjugated ketone carbonyls (1719, 1646 cm−1), aromatic
(1560, 1541 cm−1), olefin (1618 cm−1) and ether (1276 cm−1) groups. However, its 13C NMR spectrum
(Table 4, Figure S36) displayed only fourteen carbon signals which, in combination with DEPTs
and HSQC spectra (Figure S37), can be classified as two ketone carbonyls (δC 198.2 and 173.4),
one conjugated carboxyl carbonyl (δC 167.1), three oxyquaternary sp2 (δC 157.1, 152.8, 143.2), two
quaternary sp2 (δC 117.4 and 112.0), one oxymethine sp2 (δC 158.9), three methine sp2 (δC 134.9,
128.7, 104.0), one methoxyl (δC 61.0) and one methyl (δC 27.5) carbons. The 1H NMR spectrum
(Table 4, Figure S35) exhibited four singlets of aromatic/olefinic protons at δH 8.73 (1H), 7.35 (2H),
7.03 (1H), one methoxyl singlet at δH 3.75 and one methyl singlet at δH 2.29. That 5 consists of
a 7-hydroxy-6-methoxy-4-oxo-4H-chromene-5-carboxylic acid nucleus, with a substituent on C-3,
was supported by the HMBC correlations (Table 4, Figure S38) from H-2 (δH 8.73) to C-4 (δC 173.4),
C-8a (δC 152.8) and C-3 (δC 117.4); H-8 (δH 7.03) to C-4a (δC 112.0), C-6 (δC 143.2), C-7 (δC 157.1),
and C-8a, from OCH3-6 (δH 3.75) to C-6, as well as the carbon chemical shift value of OCH3-6 (δC 61.0),
characteristic of the methoxyl group flanked by one oxygenated substituent and one carboxyl group.
Like many other quaternary sp2 carbon linked to the carboxyl substituent, the intensity of the signal of
C-5 was not strong enough to be observed in the 13C NMR spectrum. Moreover, since there is no proton
two or three bonds away from C-5, it was not possible to localize the C-5 signal in the HMBC spectrum.
The existence of a 3-oxobut-1-en-1-yl substituent was supported by the presence of a singlet of two
protons at δH 7.35 (H-10 and H-11) which, through the HSQC spectrum, connected to the two methine
sp2 carbons at δC 134.9 (C-10) and δC 128.7 (C-11), as well as the HMBC correlations from H-10/H-11 to
the ketone carbonyl carbon at δC 198.2 (C-12), and from the methyl singlet at δH 2.29 (H3-13) to C-12 and
C-11. That the 3-oxobut-1-en-1-yl substituent was on C-3 was also supported by the HMBC correlations
(Table 4, Figure S38) from H-10 to C-2 and C-4 as well as from H-2 to C-10. Therefore, the structure of 5
was elucidated as 7-hydroxy-6-methoxy-4-oxo-3-[3-oxobut-1-en-1-yl]-4H-chromene-5-carboxylic acid.
The literature search revealed that 5 has never been previously reported; however its structure and
NMR data were very similar to those of PI-4, a fungal metabolite first isolated by Arai et al. [16]
from the mycelium of Penicillium italicum, a phyotoxic fungus which causes the blue-mold rot
of fruits, and later by Lu et al. [17] from the crude extract of the fungus Chaetomium indicum
(CBS.860.68). The only difference between PI-4 and 5 is the substituent on C-6 which is a
hydroxyl group in the former and a methoxyl group in the latter. Therefore, 5 is identified as
7-hydroxy-6-methoxy-4-oxo-3-[(1E)-3-oxobut-1-en-1-yl]-4H-chromene-5-carboxylic acid.
Mar. Drugs 2018, 16, 289 9 of 23
Table 4. The 1H and 13C NMR (DMSO-d6, 500.13 and 125.4 MHz) and HMBC assignment for 5.
Position δC, Type δH, (J in Hz) HMBC
2 158.9, CH 8.73, s C-3, 4, 8a, 10
3 117.4, C - -
4 173.4, CO - -
4a 112.0, C - -
5 * - -
6 143.2, C - -
7 157.1 - -
8 104.0, CH 7.03, s -
8a 152.8, C - -
9 167.1, CO - -
10 134.9, CH 7.35, s 2, 4, 12
11 128.7, CH 7.35, s 3
12 198.2, CO - -
13 17.5, CH3 2.29, s 11, 12
OCH3-6 61.0, CH3 3.75, s 6
* not observed.
The structure of 5 and the trans double bond between C-10 and C-11 are confirmed by X-ray
analysis, as shown in the ORTEP view in Figure 6.
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Compound 6 was isolated as a pale yellow viscous oil, and its molecular formula C26H20O11 was
established based on its (+)-HRESIMS m/z 509.1085 [M + H]+, (calculated 509.1084 for C26H21O11),
indicating twelve degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3443 cm−1), ketone carbonyls (1731, 1715 cm−1), conjugated ketone carbonyls (1697, 1648 cm−1),
aromatic (1634, 1556, 1596 cm−1), and ether (1261 cm−1) groups. The 13C NMR spectrum (Table 5,
Figure S40) exhibited twenty six carbon signals which can be classified, according to the DEPTs and
HSQC spectra (Table 5, Figure S42) as two ketone carbonyls (δC 204.6, 200.9), two conjugated ketone
carbonyls (δC 185.3, 172.2), ten quaternary sp2 (δC 161.3, 156.0, 155.4, 152.5, 150.2, 144.7, 141.4, 115.1,
112.3, 109.8), four methine sp2 (δC 111.1, 108.5, 102.8, 102.6), two oxyquatermary sp3 (δC 61.9 and 78.2),
two methine sp3 (δC 71.4 and 69.8), two methylene sp3 (δC 67.2 and 33.4), and two tertiary methyl
(δC 32.7 and 29.3) carbons. The 1H NMR spectrum (Table 5, Figure S39), in combination with the HSQC
spectrum, displayed four singlets of aromatic protons at δH 7.26, 7.17, 6.84 and 6.37, two methine
singlets at δH 5.41 and 5.23, two doublets of the magnetically inequivalent oxymethylene protons at
δH 4.36 (J = 12.8 Hz) and 3.59 (J = 12.8 Hz), two doublets of the magnetically inequivalent methylene
protons at δH 3.47 (J = 19.2 Hz) and 2.89 (J = 19.2 Hz), in addition to two methyl singlets at δH 2.16 and
1.51. The presence of the 7,8-dihydroxy-3-methyl-3,4-dihydro-1H,10H-pyrano[4,3-b]chromen-10-one
moiety was substantiated by the HMBC correlations (Table 5, Figure S43) from H-5 (δH 7.26, s; δC 108.0)
to C-4 (δC 172.2), C-8a (δC 152.5), C-7 (δC 150.2), and C-6 (144.7); H-8 (δH 6.84, s; δC 102.8) to C-4,
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C-8a, C-7, C-6, C-4a (δC 115.1); H-12 (δH 5.41, s; δC 71.4) to C-4, C-2 (δC 161.3), C-3 (δC 112.3), C-10
(δC 78.2), and from Me-13 (δH 1.51, s; δC 29.3) to C-2, C-10, and C-9 (δC 33.4). Another portion of
the molecule was identified as 3,3-disubstituted 6,7-dihydroxy-2,3-dihydro-4H-1-benzopyran-4-one,
based on the HMBC correlations from H-5′ (δH 7.17, s; δC 111.1) to C- 4′ (δC 185.3), C-8′a
(δC 156.0), C-7′ (δC 155.4), C-6′ (δC 141.4); H-8′ (δH 6.37, s; δC 102.6) to C-4′, C-8′a, C-6′ and
C-4′a (δC 109.8), as well as from H2-2′ (δH 4.36, J = 12.8 Hz/3.59, J = 12.8 Hz) to C-4′, C-8′a
and C-3′ (δC 61.9). That the disubstituted 6,7-dihydroxy-2,3-dihydro-4H-1-benzopyran-4-one
was connected to the 7,8-dihydroxy-3-methyl-3,4-dihydro-1H,10H-pyrano[4,3-b]chromen-10-one
moiety, through C-3′ of the former and C-12 of the latter, was confirmed by the HMBC
correlations from H-12 to C-3′ and H2-2′ to C-12. Moreover, since the HMBC spectrum
also exhibited correlations from H-12 and H2-2′ to the ketone carbonyl carbon at δC 200.9
(C-14), from H-15 (δH 5.23, s; δC 69.8) to C-9, C-10 (δC 78.2), C-14, and from Me-13 to C-15,
the 7,8-dihydroxy-3-methyl-3,4-dihydro-1H,10H-pyrano[4,3-b]chromen-10-one moiety was connected
through C-10 and C-15 of the oxan-4-one ring. The acetyl group on C-15 was corroborated by the
HMBC correlations from Me-17 (δH 2.16, s; δC 32.7) to C-15 and the carbonyl carbon at δC 204.6 (C-16),
as well as from H-15 to C-16. Taking together the molecular formula, the NMR data, and the HMBC
correlations, the planar structure of 6 was unambiguously established. In order to determine the
relative configurations of the stereogenic carbons C-10, C-12, C-15 and C-3′, the ROESY spectrum was
obtained. The ROESY spectrum (Figure S44) exhibited strong correlations from Me-13 (δH 1.51, s) to
H-15 (δH 5.23, s) and the methylene proton at δH 2.89, d (J = 19.2 Hz), implying that these three protons
are on the same face. Additionally, H-15 also shows a correlation with Me-17 (δH 2.16, s). Since the
pyran ring and the oxan-4-one ring of the 9-oxabicyclo[3.3.1]nonan-3-one ring system are in a rigid
half-chair conformation, Me-13 must be in a pseudoequatorial position while the methylene proton at
δH 2.89, d (J = 19.2 Hz) and H-15 are in a pseudoaxial position. Therefore, the acetyl group on C-15
must be in a pseudoequatorial position. This was confirmed by the higher chemical shift value (δH
3.47, d, J = 19.2 Hz) of the pseudoequatorial H-9 as it is in the deshielding zone of the carbonyl (C-16)
of the acetyl group. On the other hand, H-12 (δH 5.41, s) showed a weak correlation to one of H-2′ at
δH 3.59, d (J = 12.9 Hz). Therefore both of these protons should be in the pseudoequatorial position
since the pseudoaxial H-2′ (δH 4.36, d, J = 12.9 Hz) is under the anisotropic effect (deshielding) of the
carbonyl at C-14 of ring D. With these ROESY correlations, the relative configurations of C-10, 12, 15,
and 3′ were proposed as 10S*, 12S*, 15S*, and 3′S*. However, it is necessary to determine the absolute
configurations of these stereogenic carbons.
Since 6 could not be obtained as a suitable crystal for an X-ray analysis, the determination of
its stereogenic carbons had to be carried out by comparison of the calculated and experimental ECD
spectra. Although the ROESY correlations pointed to the relative configuration of C-10 and C-15 as
10S, 15S, it is possible that it can be 10R, 15R, thus reducing its number of possible configurations
from 16 (eight pairs of diastereoisomers) to eight (four pairs of diastereoisomers). Hence, four
computational models were constructed by combining the two configurations of C-3′ with the two
of C-12. The conformational analysis of 6 by molecular mechanics (MM2 and MMFF95 force fields)
focused on combinations of hydroxyl 120◦ rotations and rings conformations. Most diastereoisomers
did not show ring conformational freedom which limited the number of models to compute. The most
stable APFD/6-31G conformation of 6 whose absolute configurations of C-10, C-12, C-15, and C-3′ are
10S, 12S, 15S, 3′S, as deduced from ROESY correlations, is shown in Figure 7.
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Table 5. The 1H and 13C NMR (DMSO-d6, 500.13 and 125.4 MHz) and HMBC assignment for 6.
Position δC, Type δH, (J in Hz) COSY HMBC
2 161.3, C - - -
3 112.3, C - - -
4 172.2, CO - - -
4a 115.1, C - - -
5 108.0, CH 7.26, s - C-4, 6, 7, 8a
6 144.7, C - - -
7 150.2, C - - -
8 102.8, CH 6.84, s - C-4, 4a, 6, 7, 8a
8a 152.5, C - -
9α 33.4 CH2
3.47, d (19.2) H-9β C-2, 3, 10, 13, 15
9β 2.98, d (19.2) H-9α C-2, 3, 10, 13, 15
10 78.2, C - - -
12 71.4, CH 5.41, s - C-2, 3, 3′,4, 4′, 10, 14
13 29.3, CH3 1.51, s - C-2, 9, 10, 14, 15
14 200.9, CO - - -
15 69.8, CH 5.23, s H-17 C-9, 10, 13, 14, 16
16 204.6, CO - - -
17 32.7, CH3 2.16, s H-15 C-15, 16
2′α 67.7, CH2
4.36, d (12.8) H-2′β C-3′, 4, 8′a, 12, 14
2′β 3.59, d (12.8) H-2′α, 15 C-3′, 4, 8′a, 12, 14
3′ 61.9, C - - -
4′ 185.3, CO - - -
4′a 109.8, C - - -
5′ 111.1, CH 7.17, s - C-4′, 6′, 7′, 8′a
6′ 141.1, C - - -
7′ 155.4, C - - -
8′ 102.6, CH 6.37, s - C-4′, 4′a, 6′, 8′a
8′a 156.0, C - - -Mar. Drugs 2018, 16, x 12 of 24 
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1578, 1523 cm−1), and ether (1206 cm−1) groups. The 13C NMR spectrum (Table 6, Figure S46) exhibited 
twenty six carbon signals which, in combination with DEPTs and HSQC spectra (Table 6, Figure S47), 
i . t t l 6-31 confor ation of 6, r t it t l t fi ti
f s tr tri t s.
All conformations were energetically minimized and ranked using a DFT model. The lowest
energy ones, representing at least 95% of the model Boltzmann population, were used to calculate the
expected Boltzmann-averaged ECD spectra of the four 6 diastereoisomers. The fitting between the
experimental and calculated spectra is presented in Figure 8, showing that the 6 is the C-10S, C-12S,
C-3′S, C-15S enantiomer.
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Compound 7 was isolated as a pale yellow oil and the (+)-HRESIMS showed the [M + H]+ peak
at m/z 509.1085 (calculated 509.1084 for C26H21O11). Therefore, its molecular formula is C26H20O11,
indicating eighteen degrees of unsaturation. The IR spectrum showed absorption bands for hydroxyl
(3491, 3376 cm−1), conjugated ketone carbonyls (1679, 1661 cm−1), olefin (1648 cm−1), aromatic (3108,
1578, 1523 cm−1), and ether (1206 cm−1) groups. The 13C NMR spectrum (Table 6, Figure S46) exhibited
twenty six carbon signals which, in combination with DEPTs and HSQC spectra (Table 6, Figure S47),
can be classified as three carbonyls (δC 202.8, 183.6, 173.5), fifteen quaternary sp2 (δC 172.6, 155.9, 154.9,
154.2, 152.1, 150.7, 144.3, 141.6, 138.0, 132.4, 129.5, 118.6, 113.5, 1119, 103.9), five methine sp2 (δC 125.7,
110.5, 108.7, 103.3, 103.1), one methylene sp3 (δC 66.2) and two methyl (δC 32.4 and 16.6) carbons.
The 1H NMR spectrum (Table 6, Figure S45) exhibited five singlets of aromatic protons at δH 8.00, 7.45,
7.19, 6.93, and 6.34; a singlet of oxymethylene protons at δH 4.67 (2H) and two methyl singlets at δH 2.71
and 2.32. The presence of the 6,7-dihydroxy-2,3-dihydro-4H-chromen-4-one moiety was corroborated
by the HMBC correlations (Table 6, Figure S48) from H-5′ (δH 7.19, s; δC 110.5) to C-4′ (δC 183.6),
C-6′(δC 155.9), C-8′a (δC 154.9) and C-7′ (δC 141.6); H-8′ (δH 6.34, s; δC 103.3) to C-4′a (δC 111.9), C-6′,
C-7′, C-8′a, and H2-2′ (δH 4.67, s; δC 66.2) to C-3′ (δC 103.9) and C-4′ (δC 183.6). That the substituent on
C-3′ was an enolic exocyclic double bond was substantiated by the HMBC correlations from H2-2′ to
C-3′ (δC 103.9) and the enolic carbon (C-9′, δC 172.6). Another moiety was established as 7-substituted
5-acetyl-2,3-dihydroxy-6-methyl-9H-xanthen-9-one since the HMBC spectrum showed correlations
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from H-5 (δH 6.93, s; δC 103.1) to C-7 (δC 143.3), C-8a (δC 113.5), C-10a (δC 154.2); H-8 (δH 7.45, s;
δC 108.7) to C-6 (δC 150.7), C-7, C-9 (δC 173.5), C-10a; H-1 (δH 8.00, s; δC 125.7) to C-3 (δC 138.0) and
C-4a (δC 152.1); Me-11 (δH 2.32, s; δC 16.6) to C-2 (δC 129.5), C-3, C-4 (δC 132.2). Since H-1 also showed
the HMBC correlation to C-9′, the 5-acetyl-2,3-dihydroxy-6-methyl-9H-xanthen-9-one was linked to
the 6,7-dihydroxy-2,3-dihydro-4H-chromen-4-one moiety through C-9′. An extensive literature search
revealed that the structure of 7 is the same as that of the enol tautomer of the compound, named
SPF-3059-30, isolated from the acetone extract of the mycelium of Penicillium sp. SPF-3050 (FERM
BB-7663), cultured in the liquid medium [11]. However, the authors claimed that SPF-3050-30 was
isolated as a mixture of keto-enol tautomers, as supported by the duplication of the 1H and 13C
chemical shift values but without an assignment. The 13C NMR data of SPF-3050-30 displayed forty
one carbon signals, e.g., four signals for the methyl groups, three signals for the oxymethylene carbons,
two signals for the carbonyl carbon of the acetyl group, two signals for the carbonyl of the chromone
nucleus and two signals of the carbonyl of the xanthone moiety, etc., while its 1H NMR data presented
two methyl signals of the methyl group on the xanthone nucleus, two methyl signals for the acetyl
group and nine signals of aromatic protons. On the contrary, the 1H and 13C NMR spectra of 7 in
DMSO (Table 6, Figures S45 and S46) showed that it was present only in an enolic form. This is
supported by the fact that the enolic form is stabilized by the hydrogen bonding between OH-9′ and
the carbonyl of the chromone moiety (C-4′).
Table 6. The 1H and 13C NMR (DMSO-d6, 500.13 and 125.4 MHz) and HMBC assignment for 7.
Position δC, Type δH, (J in Hz) HMBC
1 125.7, CH 8.00, s C-3, 4a, 9′
2 129.5, C - -
3 138.0, C - -
4 132.2, C - -
4a 152.1, C - -
5 103.1, CH 6.93, s C-7, 8a, 10a
6 150.9, C - -
7 144.3, C - -
8 108.7, C 7.45, s C-6, 7, 9, 10a
8a 113.5, C - -
9 173.5, CO - -
9a 118.6, C - -
10a 154.2, C - -
11 16.6, CH3 2.32, s C-2, 3, 4
12 202.8, CO - -
13 32.4, CH3 2.71, s C-12
2′ 66.2, CH2 4.67, s C-3′, 4′, 8′a, 9′
3′ 103.9, C - -
4′ 183.6, CO - -
4′a 111.9, C - -
5′ 110.5, CH 7.19, s C-4′, 6′, 7′, 8′a
6′ 155.9, C - -
7′ 141.6, C - -
8′ 103.3, CH 6.34, s C-4′a, 6′, 7, 8′a
8′a 154.9, C - -
9′ 172.6, C - -
Compound 7 can be considered as a decarboxylated derivative of xanthofulvin, a semaphorin
inhibitor isolated from the culture broth of the fungus Penicillium sp. SPF-3059 [18].
Compounds 1a–e, 2a, 3a, 4, 7–9 were evaluated for their antibacterial activity against
Gram-negative and Gram-positive bacteria by disc diffusion method, and the MIC and MBC of
several reference strains and multidrug-resistant isolates from the environment were also determined.
In the disc diffusion assay, a halo of growth inhibition for all Gram-positive bacteria exposed to 8
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(Table 7) and for methicillin-resistant Staphylococcus aureus (MRSA) 66/1 exposed to 9 was detected.
However, in the range of concentrations tested, it was only possible to determine MICs for 8 (Table 7),
with MIC values of 8 mg/mL for E. faecalis ATCC 29212 and vancomycin-resistant E. faecalis (VRE)
B3/101, 16 mg/mL for E. faecium ATCC 19434, and 32 mg/mL for E. faecium 1/6/63 (VRE) and S. aureus
ATCC 29213. While it was not possible to determine the MBC for the other Gram-positive strains,
the MBC for S. aureus ATCC 29213 was 64 mg/mL (Table 7). These results suggested that 8 might have
a bacteriostatic effect.
Table 7. The antibacterial activity of 8 against a Gram-positive reference and multidrug-resistant strains.
MIC and MBC are expressed in mg/mL.
Strains E. faecalisATCC29212
E. faecium
ATCC19434
S. aureus
ATCC29213
E. faecalis
B3/101 (VRE)
E. faecium
1/6/63 (VRE)
S. aureus 66/1
(MRSA)
Disc diffusion + + + + + +
MIC 8 16 32 8 32 >64
MBC >64 >64 64 >64 >64 >64
MIC, minimal inhibitory concentration; MBC, minimal bactericidal concentration; VRE, vancomycin-resistant
Enterococcus; MRSA, methicillin-resistant Staphylococcus aureus; (-), no inhibition halo; (+), 7–9 mm inhibition halo.
The ability of the tested compounds to prevent biofilm formation was evaluated on four reference
strains by measuring the total biomass. For 8, four concentrations ranging from 2 ×MIC to 14 MIC
were tested against E. faecalis ATCC 29212, E. faecium ATCC 19434 and S. aureus ATCC 29213. For the
other compounds, since it was not possible to determine their MIC values, the highest concentration
tested in the previous assays was used. The results were interpreted using a comparative classification
that divides adherence capability of tested strains into four categories: (i) non-adherent, (ii) weakly
adherent, (iii) moderately adherent, and (iv) strongly adherent [19]. OThe optical density cut-off value
(ODc) for each microtiter plate was defined as three standard deviations above the mean OD of the
negative control. The use of this classification, which uses the negative control as the starting point
instead of using the positive control as a reference, reduces the risk of inconsistencies due to external
factors that influence biofilm production [20]. The tested compounds did not inhibit the biofilm
formation of S. aureus ATCC 29213, E. coli ATCC 25922, and P. aeruginosa ATCC 27853. However,
the biofilm forming ability of E. faecalis ATCC 29212, which is classified as a strong biofilm producer,
was impaired by 8 (MIC and 2 ×MIC) and 9 (Table 8). On the other hand, 8 was able to increase the
biofilm production of a weak biofilm producer E. faecium ATCC 19434.
Table 8. The classification of the ability of E. faecalis ATCC 29212 to adhere to and form biofilm after
exposure to 1a–e, 2a, 3a, 4, 7–9, in comparison to the untreated control.
Compound Concentration (mg/L) OD± SD Classification
1a 64 1.205 ± 0.025 strong
1b 64 1.547 ± 0.218 strong
1c 64 1.673 ± 0.308 strong
1d 64 1.522 ± 0.308 strong
1e 32 1.378 ± 0.378 strong
2a 64 1.136 ± 0.138 strong
3a 64 2.128 ± 0.248 strong
4 64 0.867 ± 0.280 strong
7 64 1.192 ± 0.239 strong
8 16 (2 ×MIC) 0.089 ± 0.002 weak
8 8 (MIC) 0.099 ± 0.006 weak
8 4 (1/2 MIC) 1.884 ± 0.220 strong
8 2 (1/4MIC) 2.358 ± 0.416 strong
9 64 0.263 ± 0.014 moderate
None 0 0.080 ± 0.002 strong
OD = optical density; SD = standard deviation; The classification used is based on criteria in [19], Average OD
value for negative control was found to be 0.055 ± 0.002, therefore the optical cut-off value (ODc) is equal to
0.055 + (3 × 0.002) = 0.061; 2 × ODc = 0.122; 4 × ODc = 0.244.
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The screening of a potential synergy between the tested compounds and clinically relevant
antimicrobial drugs revealed a slight synergy, as determined by the disc diffusion assay (Table 9).
Compound 1b, in combination with cefotaxime (CTX), resulted in a small synergistic effect, as seen by
a small increment in the zone of inhibition when compared to the inhibition halo of CTX alone in E. coli
SA/2, an extended-spectrum β-lactamase producer (ESBL). A similar effect was observed for VRE
E. faecalis B3/101 when 8 was combined with VAN. These results were confirmed by the checkerboard
method or by determining the MIC for each antibiotic in the presence of a fixed concentration of
each compound when it was not possible to determine a MIC value for the test compound. In the
latter, the concentration of each compound used was the highest concentration tested in previous
assays which did not inhibit the growth of the four multidrug-resistant strains under study. The effects
observed using the disc diffusion assay were not replicated, however, when VRE E. faecalis B3/101 was
exposed to 1d, 3a and 9, there was a two-fold reduction in the MIC of VAN. On the other hand, when
ESBL E. coli SA/2 was exposed to 1c and 7, there was at least a two-fold increase in the MIC of CTX.
When VRE E. faecium 1/6/63 was exposed to 9, there was a two-fold reduction in the MIC of VAN.
On the contrary, when it was exposed to 1e, there was at least a two-fold increase in the MIC of VAN
(Table 9). The differences in the results obtained using both techniques may be explained by different
diffusion rates of each compound in the agar plates.
Thus, in terms of antibacterial activity, 8 is the most promising. Even though no synergy with
VAN or OXA was found, this compound alone exhibited an antibiofilm activity against E. faecalis and
antibacterial activity against the reference S. aureus, E. faecalis, and E. faecium strains. Most importantly,
8 showed antibacterial activity against both vancomycin-resistant E. faecalis and vancomycin-resistant
E. faecium strains, a pathogen classified by WHO as high priority for the research and development of
new antibiotics [21]. These results call for a more in-depth study of this compound.
Table 9. The combined effect of clinically used antibiotics with 1a–e, 2a, 3a, 4, 7–9 against
multidrug-resistant strains. MICs are expressed in mg/mL.
Compound
E. coli SA/2 E. faecalis B3/101 E. faecium 1/6/63 S. aureus 66/1
CTX VAN VAN OXA
Disc Diffusion MIC Disc Diffusion MIC Disc Diffusion MIC Disc Diffusion MIC
Antibiotic + 512 - 1024 - 1024 - 64
Antibiotic + 1a - 512 - 1024 - 1024 - 64
Antibiotic + 1b + 512 - 1024 - 1024 - 64
Antibiotic + 1c - >512 - 1024 - 1024 - 64
Antibiotic + 1d - 512 - 512 - 1024 - 64
Antibiotic + 1e - 512 - 1024 - >1024 - 64
Antibiotic + 2a - 512 - 1024 - 1024 - 64
Antibiotic + 3a - 512 - 512 - 1024 - 64
Antibiotic + 4 - 512 - 1024 - 1024 - 64
Antibiotic + 7 - >512 - 1024 - 1024 - 64
Antibiotic + 8 - 512 + * - * - 64
Antibiotic + 9 - 512 - 512 - 512 - 64
MIC = minimal inhibitory concentration; (-) = no inhibition halo or no increase in the inhibition halo; (+) = halo
of inhibition or increase of the inhibition halo by 2 mm; CTX = cefotaxime; VAN = vancomycin; OXA = oxacillin.
* For this compound, the checkerboard assay was performed and, with FICI = 0.7 for E. faecalis B3/101 and FICI = 2
for E. faecium 1/6/63, no interaction between 8 and VAN was found (0.5 < FICI ≤ 4, ‘no interaction’).
3. Experimental Section
3.1. General Experimental Procedures
The melting points were determined on a Stuart Melting Point Apparatus SMP3 (Bibby Sterilin,
Stone, Staffordshire, UK) and are uncorrected. Optical rotations were measured on an ADP410
Polarimeter (Bellingham + Stanley Ltd., Tunbridge Wells, Kent, UK). Infrared spectra were recorded
in a KBr microplate in an FTIR spectrometer Nicolet iS10 from Thermo Scientific (Waltham, MA,
USA) with a Smart OMNI-Transmission accessory (Software 188 OMNIC 8.3, Thermo Scientific,
Waltham, MA, USA). 1H and 13C NMR spectra were recorded at ambient temperature on a Bruker
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AMC instrument (Bruker Biosciences Corporation, Billerica, MA, USA) operating at f300 or 500 and 75
or 125 MHz, respectively. High resolution mass spectra were measured with a Waters Xevo QToF mass
spectrometer (Waters Corporations, Milford, MA, USA) coupled to a Waters Aquity UPLC system.
A Merck (Darmstadt, Germany) silica gel GF254 was used for preparative TLC, and a Merck Si gel 60
(0.2–0.5 mm) was used for column chromatography.
3.2. Fungal Material
The fungus was isolated from the marine sponge Neopetrosia sp. which was collected, by scuba
diving at a depth of 5–10 m, from the coral reef at Samaesan Island (12◦34′36.64” N, 100◦56′59.69” E),
Chonburi province, Thailand, in April 2014. The sponge was washed with 0.01% sodium hypochlorite
solution for 1 min, followed by sterilized seawater three times, and then dried on sterile filter paper
under sterile aseptic condition. The sponge was cut into small pieces (5 mm × 5 mm) and placed
on Petri dish plates containing 15 mL potato dextrose agar (PDA) medium mixed with 300 mg/L
of streptomycin sulfate, and incubated at 28 ◦C for 7 days. The hyphal tips emerging from sponge
pieces were individually transferred onto PDA slants and maintained as pure cultures at Kasetsart
University Fungal Collection, Department of Plant Pathology, Faculty of Agriculture, Kasetsart
University, Bangkok, Thailand, for further identification. The fungal strain KUFA0220 was identified as
Penicillium erubescens, based on morphological characteristics such as colony growth rate and growth
pattern on standard media, namely Czapek’s agar, Czapek yeast autolysate agar, and malt extract
agar. Microscopic characteristics including size, shape and ornamentation of conidiophores and spores
were examined under a light microscope. This identification was confirmed by molecular techniques
using Internal Transcribed Spacer (ITS) primers. DNA was extracted from young mycelia following
a modified Murray and Thompson method [22]. Primer pairs ITS1 and ITS4 [23] were used for ITS
gene amplification. PCR reactions were conducted on Thermal Cycler and the amplification process
consisted of the initial denaturation at 95 ◦C for 5 min, 34 cycles at 95 ◦C for 1 min (denaturation),
at 55 ◦C for 1 min (annealing) and at 72 ◦C for 1.5 min (extension), followed by final extension at 72 ◦C
for 10 min. The PCR products were examined by agarose gel electrophoresis (1% agarose with 1 × TBE
buffer) and visualized under UV light after staining with ethidium bromide. DNA sequencing analyses
were performed using the dideoxyribonucleotide chain termination method [24] by Macrogen Inc.
(Seoul, Korea). The DNA sequences were edited using the FinchTV software (version 1.4, Geospiza
Inc, Seattle, WA, USA) and submitted into the BLAST program for alignment and compared to fungal
species in the NCBI database (http://www.ncbi.nlm.nih.gov/). Its gene sequences were deposited in
GenBank with accession number KY041867.
3.3. Extraction and Isolation
The fungus was cultured for one week at 28 ◦C in five Petri dishes (i.d. 90 mm) containing 20 mL
of potato dextrose agar per dish. The mycelial plugs (5 mm in diameter) were transferred to two
500 mL Erlenmeyer flasks containing 200 mL of potato dextrose broth, and incubated on a rotary shaker
at 120 rpm at 28 ◦C for one week. Fifty 1000 mL Erlenmeyer flasks, each containing 300 g of cooked
rice, were autoclaved at 121 ◦C for 15 min. After cooling to room temperature, 20 mL of a mycelial
suspension of the fungus was inoculated per flask and incubated at 28 ◦C for 30 days, after which
500 mL of ethyl acetate was added to each flask of the moldy rice and macerated for 7 days, and then
filtered with Whatman No. 1 filter paper (GE Healthcare UK Limited, Buckinghamshire, UK). The ethyl
acetate solutions were combined and concentrated under reduced pressure to yield 160 g of crude ethyl
acetate extract which was dissolved in 500 mL of CHCl3 and then filtered with Whatman No. 1 filter
paper. The chloroform solution was then washed with H2O (3 × 500 mL) and dried with anhydrous
Na2SO4, filtered and evaporated under reduced pressure to give 112 g of the crude chloroform extract
which was applied on a column of silica gel (450 g), and eluted with mixtures of petrol-CHCl3 and
CHCl3-Me2CO, wherein 250 mL fractions were collected as follow: Frs 1–147 (petrol-CHCl3, 1:1),
148–223 (petrol-CHCl3, 3:7), 224–230 (petrol-CHCl3, 1:9), 231–238 (CHCl3), 239–452 (CHCl3-Me2CO,
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9:1), 453–512 (CHCl3-Me2CO, 7:3), 512–546 (Me2CO, 7:3). Frs 75–117 were combined (1.18 g) and
applied on a column of silica gel (35 g) and eluted with mixtures of petrol-CHCl3 and CHCl3-Me2O,
wherein 100 mL sfrs were collected as follow: Sfrs 1–20 (petrol), 21–33 (petrol-CHCl3, 9:1), 34–48
(petrol-CHCl3, 7:3), 49–59 (petrol-CHCl3, 1:9), 60–65 (petrol-CHCl3), 66–80 (CHCl3-Me2CO, 9:1), 81–106
CHCl3-Me2CO, 7:3), 107–120 (Me2CO). Sfrs 35–46 were combined (103.0 mg) and purified by TLC
(Silica gel G254, CHCl3:Me2CO:HCO2H, 97:3:0.01) to give 50.2 mg of β-sitostenone [3]. Frs 238–245 were
combined (1.75 g) and precipitated in MeOH to give 202.1 mg of 8 [12–14]. Frs 246–251 were combined
(2.67 g) and precipitated in MeOH to give 472.2 mg of ergosterol 5,8-endoperoxide [4]. Frs 252–286 were
combined (493.0 mg) and crystallized in MeOH to give further 367.1 mg of ergosterol 5,8-endoperoxide.
Frs 287–299 were combined (580.4 mg) and crystallized in a mixture of CHCl3-Me2CO to give 78 mg of
2a [7,8], and the mother liquor was combined with frs 300–319 (837.2 mg) and precipitated in Me2CO to
give 10.0 mg of 1b [5]. The mother liquor (855 mg) was applied on a column chromatography of silica
gal (30 g) and eluted with petrol-CHCl3, CHCl3, CHCl3-Me2CO, and MeOH, wherein 100 mL fractions
were collected as follows: Sfrs 1–11 (petrol-CHCl3, 1:1), 12–28 (petrol-CHCl3, 3:7), 29–86 (petrol-CHCl3,
1:9), 87–126 (CHCl3), 127–135 (CHCl3-Me2CO, 9:1), 136–138 (Me2CO). Sfrs 100–126 were combined
(71.3 mg) and purified by TLC (Silica gel G254, CHCl3:Me2CO:HCO2H, 9:1:0.01) to give further 10.0 mg
of 1b. Sfrs 127 (48 mg) was crystallized in a mixture of CHCl3-Me2CO to give further 30.0 mg of 2a. Frs
343–366 were combined (1.46 g) and crystallized in MeOH to give 98.3 mg of 4, and the mother liquor
was combined with frs 367–386 (1.77 g) and recrystallized in MeOH to give further 8.0 mg of 1a [5].
The mother liquor of the combined frs 343–386 (1.36 g) was applied on a column chromatography of
silica gel (40 g), and eluted with petrol-CHCl3, CHCl3, CHCl3-Me2CO and Me2CO, wherein 100 mL
fractions were collected as follows, Sfrs 1–50 (petrol-CHCl3, 1:1), 51–88 (petrol-CHCl3, 3:7), 89–110
(petrol-CHCl3; 1:9), 111–139 (CHCl3), 140–197 (CHCl3-Me2CO, 9:1), 198–201 (CHCl3-Me2CO, 7:3),
202–215 (Me2CO). Sfrs 140–143 were combined (361.0 mg) and applied on a Sephadex LH-20 column
(10 g), and eluted with MeOH to give 12.0 mg of 1a and 10.1 mg of 9 [3]. Sfrs 147–151 were combined
(221.0 mg) and applied on a Sephadex LH-20 column (10 g) and eluted with MeOH to give 10.0 mg of
a mixture of 2b (major component) [6] and 3b. Sfrs 189–201 were combined (72.3 mg) and purified
by TLC (Silica gel G254, CHCl3:MeOH:HCO2H, 95: 5: 0.1) to give 7.1 mg of 3a [9]. Frs 387–444 were
combined (2.73 g) and applied on a column of Sephadex LH-20 (20 g) and eluted with MeOH, wherein
20 mL of 30 fractions were collected. Sfrs 11–30 were combined (472.3 mg) and crystallized in Me2CO
to give further 19 mg of 9. The mother liquor was applied on a Sephadex LH-20 column (20 g) and
eluted with a 1:1 mixture of MeOH-CHCl3 to give 15 mg of 7 [11]. Frs 517–529 were combined (1.40 g)
and crystallized in MeOH to give 26.6 mg of 1e [5], and the mother liquor was combined with frs
445–516 (6.90 g) and applied on a column of Sephadex LH-20 column (30 g) and eluted with MeOH,
wherein 20 mL fractions were collected. Sfrs 21–30 were combined (106.2 mg) and purified by TLC
(Silica gel G254, CHCl3:MeOH:HCO2H, 9:1:0.01) to give 10 mg of 3a [9,10] and 12 mg of 6. Sfrs 31–60
were combined (5.90 g) and applied on a column chromatography of silica gal (110 g) and eluted
with petrol-CHCl3, CHCl3, CHCl3-Me2CO and Me2CO, wherein 100 mL fractions were collected as
follows, Sfrs 1–26 (petrol-CHCl3, 1:1), 27–56 (petrol-CHCl3, 3:7), 57–98 (petrol-CHCl3, 1:9), 99–200
(CHCl3), 201–297 (CHCl3-Me2CO, 9:1), 298–320 (CHCl3-Me2CO, 7:3), 321–332 (CHCl3-Me2CO, 1:9),
333–358 (Me2CO). Sfrs 156–184 were combined (112.0 mg) and crystallized in Me2CO to give further
26.1 mg of 9. Sfrs 252–294 were combined (464.9 mg) and applied on a Sephadex LH-20 column
(20 g) and eluted with MeOH to give 23.0 mg of 1c. Sfrs 295–344 were combined (3.0 g), applied on
a Sephadex LH-20 column (20 g) and eluted with a 1:1 mixture of MeOH-CHCl3, wherein 20 mL
fractions were collected. Sfrs 31–72 were combined (262.9 mg) and purified by TLC (Silica gel G254,
CHCl3:MeOH:HCO2H, 9:1:0.01) to give 12.1 mg 1d [6]. Sfrs 73–96 were combined (90.6 mg) and
purified by TLC (Silica gel G254, CHCl3:MeOH:HCO2H, 9:1:0.01) to give 10.6 mg of 2c [9]. Sfrs 97–115
were combined (644.8 mg) and precipitated in MeOH to give 12 mg of a mixture of 2b and 3b, and the
mother liquor was dried (619.7 mg) and applied on a Sephadex LH-20 column (10 g) and eluted with a
1:1 mixture of CHCl3:MeOH, wherein 70 sub-fractions (2 mL each) were collected. Sfrs 25–32 were
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combined (40.8 mg) and precipitated in MeOH to give 10 mg of 1e [5]. Sfrs 33–45 were combined
(70.1 mg) and purified by TLC (Silica gel G254, CHCl3:MeOH:HCO2H, 9:1:0.01) to give 6 mg of 5. Sfrs
46–56 were combined (65.3 mg) and precipitated in MeOH to give further 7 mg of 5.
3.3.1. 1-Hydroxy-12-methoxycitromycin (1c)
White solid, mp 232–233 ◦C (CHCl3/MeOH); IR (KBr) νmax 3420 (br), 2921, 1662, 1627, 1594, 1555,
1517, 1453, 1270 cm−1; For 1H and 13C spectroscopic data (DMSO-d6, 500.13 and 125.4 MHz), see
Table 1; (+)-HRESIMS m/z 277.0715 [M + H]+ (calculated for C14H13O6, 277.0712).
3.3.2. Erubescenschromone A [(3S)-6,7-Dihydroxy-5′-methyl-3′H,4H-spiro[chromene-3,2′-furan]-3′,
4-dione (4)]
White crystal, mp 150–152 ◦C (CHCl3/MeOH); [α]23D −40.0 (c 0.05, CDCl3); IR (KBr) νmax 3491,
3376, 3108, 2969, 1679, 1661, 1648, 1578, 1523, 1479, 1276 cm−1; For 1H and 13C spectroscopic data
(DMSO-d6, 500.13 and 125.4 MHz), see Table 3; (+)-HRESIMS m/z 263.0596 [M + H]+ (calculated for
C13H11O6, 263.0556).
3.3.3. 7-Hydroxy-6-methoxy-4-oxo-3-[(1E)-3-oxobut-1-en-1-yl]-4H-chromene-5-carboxylic Acid (5)
White crystal, mp 276–277 ◦C (CHCl3/MeOH); IR (KBr) νmax 3446, 2922, 1719, 1646, 1618, 1560,
1541, 1521, 1276 cm−1; For 1H and 13C spectroscopic data (DMSO, 500.13 and 125.4 MHz), see Table 4;
(+)-HRESIMS m/z 305.0667 [M + H]+ (calculated for C15H13O7, 305.0661).
3.3.4. Erubescenschromone B (6)
Yellowish oil; [α]23D −150.0 (c 0.04, MeOH); IR (KBr) νmax 3443 (br), 2922, 1731, 1715, 1697, 1648,
1634, 1556, 1540, 1506, 1261 cm−1; For 1H and 13C spectroscopic data (DMSO-d6, 500.13 and 125.4 MHz),
see Table 5; (+)-HRESIMS m/z 509.1085 [M + H]+ (calculated for C26H21O11, 509.1084).
3.3.5. SPF-3059-30 (7)
Yellowish oil; IR (KBr) νmax 3491, 3376, 3108, 2969, 1679, 1661, 1648, 1578, 1523, 1479, 1276 cm−1;
For 1H and 13C spectroscopic data (DMSO-d6, 500.13 and 125.4 MHz), see Table 6; (+)-HRESIMS m/z
491.0974 [M + H]+ (calculated for C26H19O10, 491.0978).
3.4. Electronic Circular Dichroism (ECD)
Electronic Circular Dichroism (ECD) of 3a and 6
The ECD spectra of 3a and 6 (1.5 mM in methanol) were obtained in a Jasco J-815 CD
spectropolarimeter (Jasco, Mary’s Court, Easton, MD, USA) with a 0.01 mm cell (40 accumulations
for 3a). The dihedral driver and MMFF95 minimizations were done in Chem3D Ultra (Perkin-Elmer
Inc., Waltham, MA, USA). All DFT minimizations with model chemistries APFD/6-31G and
APFD/6-311+G(2d,p) [25] as well as ECD spectral calculations (TD-APFD) were performed with
Gaussian 16W (Gaussian Inc., Wallingford, CT, USA) using an IEFPCM solvation model for methanol.
The simulated spectral lines for 3a (Figure 3) and 6 (Figure 8) were obtained by summation of Gaussian
curves, as recommended in Reference [26]. A line broadening of 0.3 eV was applied to all transitions to
generate the calculated line.
3.5. X-ray Crystal Structures
3.5.1. X-ray Crystal Structure of 4
A single crystal of 4 was mounted on a cryoloop using paratone. X-ray diffraction data were
collected at 290 K with a Gemini PX Ultra equipped with CuKα radiation (λ = 1.54184 Å). The crystal
was monoclinic, space group P21/n, cell volume 1245.43(7) Å3 and unit cell dimensions a = 12.3445(4)
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Å, b = 7.8088(3) Å and c = 12.9397(5) Å and angle β = 93.165(3)◦ (uncertainties in parentheses). There are
two molecules in the asymmetric unit, one Erubescenschromone A molecule and one water molecule,
and the calculated crystal density is 1.495 g/cm−3. The structure was solved by direct methods using
SHELXS-97 and refined with SHELXL-97 [27]. Carbon and oxygen atoms were refined anisotropically.
Hydrogen atoms were directly found from difference Fourier maps and were refined freely with isotropic
displacement parameters. The refinement converged to R (all data) = 6.32% and wR2 (all data) = 11.26%.
Full details of the data collection and refinement and tables of atomic coordinates, bond lengths
and angles, and torsion angles have been deposited with the Cambridge Crystallographic Data Centre
(CCDC 1856735).
3.5.2. X-ray Crystal Structure of 5
A single crystal of 5 was mounted on a cryoloop using paratone. X-ray diffraction data
were collected at 290 K with a Gemini PX Ultra equipped with CuKα radiation (λ = 1.54184 Å).
The crystal was monoclinic, space group P21/c, cell volume 1324.77(16) Å3 and unit cell dimensions
a = 11.6888(8) Å, b = 7.7695(4) Å and c = 14.9560(12) Å and angle β = 102.748(7)◦ (uncertainties in
parentheses). The calculated crystal density was 1.525 g·cm−3. The structure was solved by direct
methods using SHELXS-97 and refined with SHELXL-97 [27]. Carbon and oxygen atoms were refined
anisotropically. Hydrogen atoms from one of the methyl groups were placed at their idealized
positions using appropriate HFIX instructions in SHELXL and included in subsequent refinement cycles,
all the others were directly found from difference Fourier maps and were refined freely with isotropic
displacement parameters. The refinement converged to R (all data) = 12.24% and wR2 (all data) = 14.96%.
Full details of the data collection and refinement and tables of atomic coordinates, bond lengths
and angles, and torsion angles have been deposited with the Cambridge Crystallographic Data Centre
(CCDC 1859409).
3.6. Antibacterial Activity Bioassays
3.6.1. Bacterial Strains and Growth Conditions
Gram-positive bacteria included Staphylococcus aureus ATCC 29213, Enterococcus faecium ATCC
19434, Enterococcus faecalis ATCC 29212, methicillin-resistant Staphylococcus aureus (MRSA) 66/1 isolated
from public buses [28], and vancomycin-resistant enterococci (VRE) Enterococcus faecium 1/6/63
and Enterococcus faecalis B3/101 isolated from river water [29]. Gram-negative strains comprised
Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853 and the clinical isolate SA/2,
an extended-spectrum β-lactamase producer (ESBL). All strains were kept in Trypto-Casein Soy
agar (TSA—Biokar Diagnostics, Allone, Beauvais, France) slants, at room temperature, in the dark.
Before each assay, all strains were cultured in Mueller-Hinton agar (MH-Biokar Diagnostics, Allone,
Beauvais, France) and incubated overnight at 37 ◦C. Stock solutions of the compounds were prepared
in dimethyl sulfoxide (DMSO—Alfa Aesar, Kandel, Germany) and kept at −20 ◦C. With the exception
of 1e, 10 mg/mL stock solutions were prepared. Compound 1e was less soluble in DMSO than other
compounds, so a 2 mg/mL stock solution was prepared. In the experiments, the final concentration
of DMSO in the medium was below 1%, as recommended by the Clinical and Laboratory Standards
Institute [30].
3.6.2. Antimicrobial Susceptibility Testing
The antimicrobial activity of the compounds was screened using the Kirby-Bauer method, as
recommended by the CLSI [31]: 6 mm blank paper discs (Liofilchem, Roseto degli Abruzzi TE, Italy)
were impregnated with 15 µg of each compound, and the blank paper discs impregnated with DMSO
were used as negative control. MH inoculated plates were incubated for 18–20 h at 37 ◦C. The results
were evaluated by measuring the inhibition halos. The minimal inhibitory concentration (MIC) was
performed in accordance with the recommendations of the CLSI [32]. Two-fold serial dilutions of
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the compounds were prepared in cation-adjusted Mueller-Hinton broth (CAMHB—Sigma-Aldrich,
St. Louis, MO, USA) within the concentration range 64–0.063 mg/L, except for 1e, for which the highest
concentration tested was 32 mg/L. Colony forming unit counts of the inoculum were conducted in
order to determine the initial inoculum size (which should be approximately 5 × 105 CFU/mL).
The 96-well U-shaped untreated polystyrene microtiter plates were incubated for 16–20 h at 37 ◦C
and the MIC was determined as the lowest concentration of compound that prevented visible growth.
The minimal bactericidal concentration (MBC) was determined by spreading 100 µL of the content
of the wells with no visible growth on the MH plates. The MBC was determined as the lowest
concentration of compound that killed 99.9% of the initial inoculum after overnight incubation at
37 ◦C [33]. These assays were conducted for reference and multidrug-resistant strains.
3.6.3. Biofilm Formation Inhibition Assay
The effect of all compounds on biofilm formation was evaluated using the crystal violet method,
as follows: the highest concentration of the tested compound in the MIC assay was added to bacterial
suspensions of 1 × 106 CFU/mL prepared in unsupplemented Tryptone Soy broth (TSB—Biokar
Diagnostics, Allone, Beauvais, France) or TSB supplemented with 1% (p/v) glucose [D-(+)-Glucose
anhydrous for molecular biology, PanReac AppliChem, Barcelona, Spain] for Gram-positive strains.
When it was possible to determine a MIC, four concentrations of compound were tested, i.e., 2 ×MIC,
MIC, 12 MIC and
1
4 MIC. A control with appropriate concentration of DMSO, as well as a negative
control (TSB alone), was included. Sterile 96-well flat-bottomed untreated polystyrene microtiter plates
were used. After a 24 h incubation at 37 ◦C, the biofilms were heat-fixed for 1 h at 60 ◦C and stained
with 0.5% (v/v) crystal violet (Química Clínica Aplicada, Amposta, Spain) for 5 min. The stain was
solubilized with 33% (v/v) acetic acid (Acetic acid 100%, AppliChem, Darmstadt, Germany) and the
biofilm biomass was quantified by measuring the absorbance of each sample at 570 nm in a microplate
reader (Thermo Scientific Multiskan® EX, Thermo Fisher Scientific, Waltham, MA, USA) [20,34]. This
assay was performed for reference strains.
3.6.4. Antibiotic Synergy Testing
The potential synergy between the compounds and clinically relevant antimicrobial drugs was
screened using the Kirby-Bauer method, as previously described [35]. A set of antibiotic discs (Oxoid,
Basingstoke, UK) to which the isolates were resistant was selected: cefotaxime (CTX, 30 µg) for E. coli
SA/2, vancomycin (VAN, 30 µg) for E. faecalis B3/101 and E. faecium 1/6/63, and oxacillin (OXA,
1 µg) for S. aureus 66/1. Antibiotic discs impregnated with 15 µg of each compound were placed on
seeded MH plates. The controls used included antibiotic discs alone, blank paper discs impregnated
with 15 µg of each compound alone and blank discs impregnated with DMSO. Plates with CTX
were incubated for 18–20 h and plates with VAN and OXA were incubated for 24 h at 37 ◦C [30].
The potential synergy was considered when the inhibition halo of an antibiotic disc impregnated with
the compound was greater than the inhibition halo of the antibiotic or compound-impregnated blank
disc alone. The combined effect of the compounds and clinical relevant antimicrobial drugs was also
evaluated by determining the antibiotic MIC in the presence of each compound. Briefly, when it was
not possible to determine a MIC value for the test compound, the MIC of CTX (Duchefa Biochemie,
Haarlem, The Netherlands), VAN (Oxoid, Basingstoke, UK), and OXA (Sigma-Aldrich, St. Louis,
MO, USA) for the respective multidrug-resistant strain was determined in the presence of the highest
concentration of each compound tested in previous assays. In the case of 1e, the concentration used
was 32 mg/L while it was 64 mg/L for the other compounds. The antibiotic tested was serially diluted
whereas the concentration of each compound was kept fixed. Antibiotic MICs were determined as
described above. For 7, it was possible to determine the MIC for E. faecalis B3/101 and E. faecium
1/6/63, so the checkerboard method was used instead, as previously described [34]. The fractional
inhibitory concentrations (FIC) were calculated as follows: FIC of compound = MIC of compound
combined with antibiotic/MIC compound alone, and FIC antibiotic = MIC of antibiotic combined with
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a compound/MIC of antibiotic alone. The FIC index (FICI) was calculated as the sum of each FIC and
interpreted as follows: FICI ≤ 0.5, ‘synergy’; 0.5 < FICI ≤ 4, ‘no interaction’; FICI > 4, ‘antagonism’ [36].
4. Conclusions
Marine-derived fungi have proved to be important sources of bioactive secondary metabolites,
many of which exhibit cytotoxic and antibiotic activities. One of the most studied marine-derived fungi
is of the genus Penicillium. In the past ten years, the Penicillium species from the marine environment
received more attention than other fungal genera since compounds isolated from members of the
Penicillium genus accounted for more than 25% of compounds of marine fungal origin. Although
polyketides are the major secondary metabolites isolated from marine-derived Penicillium species,
other structural classes of secondary metabolites such as alkaloids, terpenoids, and sterols are also
isolated. In this work, we have described isolation and structure elucidation of two common fungal
sterol derivatives: β-sitostenone and ergosterol 5,8-endoperoxide, fifteen polyketides, five of which
have not been previously described, and a macrocyclic ether containing 1,4-disubstituted phenyl and
succinamide moiety called GKK1032B, from the culture of the fungus P. erubescens strain KUFA 0220,
which was isolated from the marine sponge Neopetrosia sp., collected from the Gulf of Thailand. From
the compounds evaluated for their antibacterial activity against Gram-positive and Gram-negative
bacteria of reference strains and multidrug-resistant isolates, their capacity to inhibit biofilm formation
and synergistic effect, only GKK1032B displayed significant activities in all assays. Although the rest
of the compounds, including those which have not been previously described, did not show significant
antibacterial activity, it does not mean that they are void of bioactivities. Therefore, it is necessary
to test these compounds in other bioassay platforms to explore their potential. Finally, it is worth
mentioning that this is the first report of the chemical study of the marine-derived P. erubescens.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-3397/16/8/
289/s1, Figure S1: Structures of β-sitosteanone and ergosterol-5,8-endoperoxide, isolated from the marine
sponge-associated fungus Penicillium reubescens KUFA0220, Figures S2–S50 and S52–S53: 1D and 2D NMR
spectra of isolated compounds, Figure S51: Ortep view of GKK1032B (8).
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